Total Payments
$2,247
2024 Payments
$168.62
Companies
17
Transactions
58
Medicare Patients
11,200
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$2,247 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,247 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $820.69 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $294.04 | 11 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $241.03 | 6 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $209.22 | 2 | $0 (2021) |
| ABBVIE INC. | $175.87 | 6 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $117.43 | 1 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $91.97 | 4 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $79.18 | 2 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $38.54 | 2 | $0 (2018) |
| Harrow Eye, LLC | $35.36 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.62 | 6 | ABBVIE INC. ($65.05) |
| 2023 | $254.52 | 9 | AbbVie Inc. ($92.63) |
| 2022 | $219.15 | 5 | NEW WORLD MEDICAL,INC. ($117.43) |
| 2021 | $385.21 | 9 | Allergan, Inc. ($149.76) |
| 2020 | $33.91 | 2 | Novartis Pharmaceuticals Corporation ($17.02) |
| 2019 | $651.05 | 15 | Allergan Inc. ($352.69) |
| 2018 | $161.83 | 8 | Novartis Pharmaceuticals Corporation ($110.18) |
| 2017 | $372.46 | 4 | Allergan Inc. ($288.24) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $35.36 | General |
| Category: OPTOMETRY | ||||||
| 12/12/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: EYE CARE | ||||||
| 05/08/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Ophthalmology | ||||||
| 05/02/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/12/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Ophthalmology | ||||||
| 03/11/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: EYE CARE | ||||||
| 12/14/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug), RETISERT | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Ophthalmology | ||||||
| 11/27/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: EYE CARE | ||||||
| 11/13/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $23.43 | General |
| 11/09/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/24/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: EYE CARE | ||||||
| 05/23/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/18/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: EYE CARE | ||||||
| 04/26/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Ophthalmology | ||||||
| 02/11/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.07 | General |
| 12/02/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: RETINA | ||||||
| 10/01/2022 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Streamline Surgical System, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $117.43 | General |
| Category: Ophthalmology | ||||||
| 07/21/2022 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Ophthalmology | ||||||
| 07/20/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/03/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/17/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $149.76 | General |
| Category: RETINA | ||||||
| 10/20/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2021 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/26/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/09/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,638 | 6,437 | $2.3M | $602,557 |
| 2022 | 16 | 2,909 | 6,376 | $2.4M | $625,587 |
| 2021 | 15 | 2,527 | 5,610 | $2.1M | $568,726 |
| 2020 | 16 | 3,126 | 6,096 | $2.2M | $646,148 |
Total Patients
11,200
Total Services
24,519
Medicare Billing
$2.4M
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 46 | 380 | $940,500 | $260,904 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 597 | 1,464 | $362,500 | $125,614 | 34.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 166 | 591 | $168,050 | $48,477 | 28.8% |
| 92134 | Imaging of retina | Office | 2023 | 670 | 1,656 | $173,655 | $46,606 | 26.8% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 12 | 266 | $130,340 | $38,891 | 29.8% |
| 92250 | Photography of the retina | Office | 2023 | 409 | 960 | $135,213 | $26,152 | 19.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 107 | 328 | $194,470 | $18,461 | 9.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $50,160 | $13,542 | 27.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 94 | 104 | $22,230 | $10,143 | 45.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 246 | 360 | $52,090 | $5,846 | 11.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 13 | 15 | $20,130 | $2,667 | 13.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 33 | 40 | $12,640 | $2,594 | 20.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 89 | 117 | $16,965 | $1,176 | 6.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,280 | $559.10 | 24.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 12 | $1,865 | $537.69 | 28.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 12 | 12 | $2,256 | $386.74 | 17.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 48 | 408 | $1.0M | $290,553 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 505 | 896 | $218,869 | $85,813 | 39.2% |
| 92134 | Imaging of retina | Office | 2022 | 674 | 1,648 | $172,905 | $47,460 | 27.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 165 | 570 | $165,330 | $47,096 | 28.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 335 | 531 | $167,499 | $37,358 | 22.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 12 | 231 | $113,190 | $34,317 | 30.3% |
| 92250 | Photography of the retina | Office | 2022 | 399 | 916 | $128,232 | $24,901 | 19.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 115 | 345 | $207,900 | $18,477 | 8.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 111 | 111 | $46,398 | $12,613 | 27.2% |
About Dr. Stanislav Zhuk, M.D
Dr. Stanislav Zhuk, M.D is a Ophthalmology healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922201870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanislav Zhuk, M.D has received a total of $2,247 in payments from pharmaceutical and medical device companies, with $168.62 received in 2024. These payments were reported across 58 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,247).
As a Medicare-enrolled provider, Zhuk has provided services to 11,200 Medicare beneficiaries, totaling 24,519 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Metairie, LA
- Active Since 06/07/2007
- Last Updated 10/08/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1922201870
Products in Payments
- OZURDEX (Drug) $892.30
- EYLEA (Biological) $344.41
- Kahook Dual Blade (Device) $117.43
- XIPERE (Drug) $91.97
- EYLEA AFLIBERCEPT INJECTION (Biological) $84.22
- BEOVU (Drug) $58.87
- LOTEMAX GEL (Drug) $38.54
- YUTIQ (Drug) $35.62
- IHEEZO (Drug) $35.36
- Syfovre (Drug) $31.11
- ACTHAR (Biological) $29.91
- EYLEA HD (Biological) $21.62
- Vabysmo (Drug) $20.24
- Iluvien (Drug) $17.51
- TEPEZZA (Drug) $16.71
- DUREZOL (Drug) $14.38
- BROLUCIZUMAB (Drug) $9.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Metairie
Dr. Ethan Stern, Md, MD
Ophthalmology — Payments: $14,351
Ophthalmology $14,351
John Frisbee, Md, MD
Ophthalmology — Payments: $12,347
Ophthalmology $12,347
Gwen Cousins, Md, MD
Ophthalmology — Payments: $10,416
Ophthalmology $10,416
Benjamin Guidry, Md, MD
Ophthalmology — Payments: $9,044
Ophthalmology $9,044
Dr. Henry Haley, M.d, M.D
Ophthalmology — Payments: $8,019
Ophthalmology $8,019
Scott Lanoux, Md, MD
Ophthalmology — Payments: $7,607
Ophthalmology $7,607